AI empowers Cisco collaboration to help Takeda Pharmaceutical work smarter
As the leader in today's collaborative market, Cisco is helping global enterprise Takeda Pharmaceutical to continuously upgrade its collaboration system to create a collaborative experience that integrates humanity, automation, and intelligence. It uses technology to improve work efficiency and collaboratively release employee intelligence. Takeda Pharmaceutical's leading deployment in collaboration systems demonstrates its care for its employees, respect for its customers, and commitment to innovation and quality, which will help Takeda Pharmaceutical to win the trust of society and customers.
In 1781, the founder Takeda Masahiro I created Takeda to treat patients as their children. Although the health care industry has undergone many changes since the establishment of Takeda, it is always the company's business philosophy to focus on patients. As a pharmaceutical company with operations in more than 70 countries and regions and 30,000 employees, Takeda has a clear understanding of the use of collaboration. The modern collaborative communication method enables Takeda's R&D wisdom, excellent service and corporate culture to be effectively covered. Touched. Takeda China has a different deployment of a human-based collaboration system. When other companies just used IP phones, Takeda China has deployed the Cisco TelePresence System. Takeda deployed Cisco IX5000 immersive telepresence in the Shanghai office, deployed Cisco Webex DX80 desktop collaboration terminal in other branches such as Beijing, and used real-time video communication to make Takeda pharmaceutical companies and partners in Beijing, Tianjin, Shanghai and other parts of China. Video collaboration and communication. The use of advanced telepresence system makes the collaboration communication of Takeda Pharmaceuticals full of humanized features: taking IX5000 three-screen telepresence as an example, its unique 1:1 real person and other large restore, whiteboard image dual-flow mode real-time sharing and so on, Make the company's collaborative communication more efficient.
Recently, the business scale of Takeda Pharmaceuticals Beijing Co., Ltd. has been continuously expanded, and the relocation of office space has triggered the need for redeployment of collaborative meeting rooms. Takeda Pharmaceutical has decisively selected the world's leading new technology to replace the old video collaboration terminal. With the Cisco MX800 collaborative conference room terminal product, employees can focus on the collaborative conference itself, and feel the intelligence in the humanized collaborative experience. Charm. The super-pleasant sensory experience is the first experience that MX800 brings to Takeda's employees. Compared to the previous 23-inch single screen, the MX800 has two 70-inch LED large screens and 1080p HD display, which makes the participants feel immersive. General use feeling. 2 large screens, one screen can maximize the playback of PPT content, and the screen displays local and counterpart lenses, which enhances the collaborative communication experience from multiple angles.
In addition, the MX800's smart dual camera features a speaker tracking function that intelligently “finds†colleagues who are currently speaking, and can automatically perform alignment and focusing in an instant; the built-in amplifier and speaker array system allows employees to stay close to or away from the video. The terminal can clearly hear the voice without missing any communication details. In this way, there is no need for the participants to manually adjust the site manually, and there is no need to integrate any third-party audio system. The intelligence of the product alone greatly saves the time cost of the employee maintenance meeting. Not only that, but for the pre-meeting conference setup, employees can complete the previous 60 seconds of operation in just a few seconds with a simple touchpad. The automatic reminder of the participation reminds you to complete the participation in an instant. This intelligent application enables Wutian Pharmaceutical's collaborative meeting room to achieve the perfect unity of humanization and automation.
In the face of future collaborative development, Takeda Pharmaceutical has developed a clear plan - "intelligent" route. Within two years, Takeda Pharmaceutical will gradually upgrade the old video terminals of all branches to the Cisco Webex Room series powered by artificial intelligence (AI). With the features of the Cisco Webex Room's automatic statistic, smart voice assistant, etc., AI gives more powerful energy for collaborative communication.
Lu Yong, IT technical director of Takeda Pharmaceuticals, said: "Our conference room has experienced the stage from humanization to automation. Artificial intelligence will be the future development trend. We have been paying attention to the application of AI in the collaborative conference room field, focusing on industries such as Cisco. Leading manufacturers' every move."
Wei Songbin, senior vice president of Cisco Greater China and general manager of the product department, said: "The concept of Cisco Collaboration is to help customers experience high-quality collaboration in every room, every desk, every pocket. Cisco I am very pleased to help Takeda Pharmaceutical achieve effective collaboration and communication through unique artistic and high-tech collaborative products, further motivate employees' innovative potential and empower the company to develop intelligently for the future."
Feline Infectious Peritonitis (FIP), referred to as Feline Infectious Peritonitis (FIP), is a fatal abnormal immune response that occurs in cats. It is caused by the mutation of the feline coronavirus carried by cats. As a high-incidence and fatal disease of pet cats, the current incidence of feline abdominal transmission is about 10%.
The symptoms of cats are usually divided into two categories, namely wet FIP and dry FIP, of which wet FIP accounts for the majority of all cases. About 70%, manifested as abdominal pleural effusion, abnormal bulging; dry FIP cats have different symptoms, depending on the type of organ affected by the virus.
So far, all feline feline feline treatments are based on the characteristics of the disease, and GS-441524 can play a role in the treatment of feline feline disease. Therefore, the therapeutic effect of GS-441524 is obviously more ideal, the dose used is less, the treatment cycle is shorter, and the efficacy, safety and convenience of operation are all good. Because of this, GS-441524 is considered by many pet owners and veterinarians to be a magic medicine that can effectively treat feline abdominal infection.
Gs 441524 Fip,Fip Treatment Gs441,Gs 441524 Fipv Cats,Gs 441524 For Fip
XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.rhinebioteches.com